2,3-Dihydrospiro[indene-1,4'-piperidine] hydrochloride → HCID 178469968, compound
Reaction equation
[CH2:1]([O:3][C:4]([C:6]1[CH:7]=[N:8][N:9]2[C:14]([OH:15])=[C:13]([C:16]([OH:18])=O)[CH:12]=[N:11][C:10]=12)=[O:5])[CH3:2].Cl.[NH:20]1[CH2:25][CH2:24][C:23]2([C:33]3[C:28](=[CH:29][CH:30]=[CH:31][CH:32]=3)[CH2:27][CH2:26]2)[CH2:22][CH2:21]1>>[CH2:1]([O:3][C:4]([C:6]1[CH:7]=[N:8][N:9]2[C:14]([OH:15])=[C:13]([C:16]([N:20]3[CH2:25][CH2:24][C:23]4([C:33]5[C:28](=[CH:29][CH:30]=[CH:31][CH:32]=5)[CH2:27][CH2:26]4)[CH2:22][CH2:21]3)=[O:18])[CH:12]=[N:11][C:10]=12)=[O:5])[CH3:2]Participants
3
Procedure
In the same manner as in Example 1, step 2 and using 3-ethoxycarbonyl-7-hydroxypyrazolo[1,5-a]pyrimidine-6-carboxylic acid (0.27 g, 1.06 mmol) obtained in Example 19, step 2 and spiro[indane-1,4′-piperidine]hydrochloride (0.3 g, 1.32 mmol), the title compound (0.29 g, 64%) was obtained.
Sources & evidence
- ORD record
- ord-f5c7226d9699472486c38f7b6c534004
- Source dataset
- uspto-grants-2014_05
- Patent number
- US08729264B2
Reaction notes
Loading…